82 related articles for article (PubMed ID: 18218828)
1. Reply: letter to the editor in response to Morton et al. (2007) Carcinogenesis, 28, 1759-1764.
Bailey JE; Skare JA
Carcinogenesis; 2008 Sep; 29(9):1851. PubMed ID: 18218828
[No Abstract] [Full Text] [Related]
2. Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response.
Zahm SH; Morton LM; Bernstein L; Wang SS; Colt JS; Severson RK; Welch R; Hartge P
Carcinogenesis; 2008 May; 29(5):1084-5. PubMed ID: 18212328
[No Abstract] [Full Text] [Related]
3. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH
Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066
[TBL] [Abstract][Full Text] [Related]
4. N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus.
Cooper GS; Treadwell EL; Dooley MA; St Clair EW; Gilkeson GS; Taylor JA
J Rheumatol; 2004 Jan; 31(1):76-80. PubMed ID: 14705222
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.
Zhang Y; Hughes KJ; Zahm SH; Zhang Y; Holford TR; Dai L; Bai Y; Han X; Qin Q; Lan Q; Rothman N; Zhu Y; Leaderer B; Zheng T
Am J Epidemiol; 2009 Nov; 170(10):1222-30. PubMed ID: 19822571
[TBL] [Abstract][Full Text] [Related]
6. Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers.
Jourenkova-Mironova N; Wikman H; Bouchardy C; Mitrunen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1999 Aug; 9(4):533-7. PubMed ID: 10780274
[No Abstract] [Full Text] [Related]
7. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer.
Yeh CC; Sung FC; Tang R; Chang-Chieh CR; Hsieh LL
Dis Colon Rectum; 2009 Jan; 52(1):104-11. PubMed ID: 19273964
[TBL] [Abstract][Full Text] [Related]
9. Use of hair dyes before 1980 linked to non-Hodgkin's lymphoma.
Mayo Clin Womens Healthsource; 2004 Jul; 8(7):3. PubMed ID: 15218444
[No Abstract] [Full Text] [Related]
10. [Polymorphism of N-acetyltransferase-2 and pathogenesis of neoplastic diseases].
Kłodowska-Duda GA; Samelska JA; Opala GM
Wiad Lek; 2005; 58(3-4):212-7. PubMed ID: 16119167
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
[TBL] [Abstract][Full Text] [Related]
12. Hair dye use and non-Hodgkin lymphoma.
Zahm SH; Fraumeni JF
JAMA; 2005 Sep; 294(10):1205; author reply 1205. PubMed ID: 16160127
[No Abstract] [Full Text] [Related]
13. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.
Hein DW; Rustan TD; Bucher KD; Miller LS
J Pharmacol Exp Ther; 1991 Nov; 259(2):699-704. PubMed ID: 1941618
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2.
Lee E; Huang Y; Zhao B; Seow-Choen F; Balakrishnan A; Chan SH
J Toxicol Sci; 1998 Jul; 23 Suppl 2():140-2. PubMed ID: 9760451
[No Abstract] [Full Text] [Related]
15. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.
Hein DW; Rustan TD; Bucher KD; Martin WJ; Furman EJ
Drug Metab Dispos; 1991; 19(5):933-7. PubMed ID: 1686239
[TBL] [Abstract][Full Text] [Related]
16. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
[TBL] [Abstract][Full Text] [Related]
17. Characterization of N-acetyltransferase 1 activity in human keratinocytes and modulation by para-phenylenediamine.
Bonifas J; Scheitza S; Clemens J; Blömeke B
J Pharmacol Exp Ther; 2010 Jul; 334(1):318-26. PubMed ID: 20406859
[TBL] [Abstract][Full Text] [Related]
18. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
[No Abstract] [Full Text] [Related]
19. An N-ethyl-N-nitrosourea-induced mutation in N-acetyltransferase 1 in mice.
Erickson RP; McQueen CA; Chau B; Gokhale V; Uchiyama M; Toyoda A; Ejima F; Maho N; Sakaki Y; Gondo Y
Biochem Biophys Res Commun; 2008 May; 370(2):285-8. PubMed ID: 18373979
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Brockmöller J; Cascorbi I; Kerb R; Roots I
Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
